Intervention

NMDAE

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting6

Common conditions3

Lead sponsors shown1

Clinical trials

6 shown

Sex Differences in NMDA-enhancing Treatment of SchizophreniaNCT07122895 · 2025-09-16

NMDA-enhancing Treatment for Cognitive Dysfunction of SchizophreniaNCT06021197 · 2023-10-12

NMDA Modulation in Antidepressant Nonresponders With Major Depressive DisorderNCT05136755 · 2022-01-25

Early Intervention of Prodromal Schizophrenia Using an NMDA EnhancerNCT05052853 · 2021-11-01

Monotherapy of an NMDA Enhancer for SchizophreniaNCT04745143 · 2018-01-01

NMDA Modulation in Major Depressive DisorderNCT04637620 · 2017-06-01

Common conditions

Schizophrenia3 Major Depressive Disorder2 Prodromal Schizophrenia1

Leading sponsors

China Medical University Hospital6

Trial status mix

RECRUITING6

Phase mix

PHASE26

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.